Matt Hewitt
Stock Analyst at Craig-Hallum
(3.95)
# 640
Out of 4,711 analysts
45
Total ratings
53.85%
Success rate
11.33%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLOV Clover Health Investments | Initiates: Buy | $6 | $3.23 | +85.76% | 1 | Dec 17, 2024 | |
| CSBR Champions Oncology | Maintains: Buy | $6 → $8 | $7.51 | +6.60% | 3 | Dec 12, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $27.39 | +16.83% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $44.98 | +42.29% | 6 | Oct 31, 2024 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $135 → $140 | $114.64 | +22.12% | 3 | Jul 9, 2024 | |
| SLP Simulations Plus | Reiterates: Buy | $56 | $28.58 | +95.94% | 7 | Jul 3, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $4.08 | +145.10% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $19.44 | +54.32% | 3 | May 2, 2024 | |
| CDMO Avid Bioservices | Maintains: Buy | $22 → $16 | $12.30 | +30.08% | 4 | Dec 8, 2023 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $4.24 | +65.09% | 1 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $207 → $200 | $144.46 | +38.45% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.50 | +185.71% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $9.44 | +217.80% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $3.00 | +13,233.33% | 1 | Jan 4, 2022 |
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $3.23
Upside: +85.76%
Champions Oncology
Dec 12, 2024
Maintains: Buy
Price Target: $6 → $8
Current: $7.51
Upside: +6.60%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $27.39
Upside: +16.83%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $44.98
Upside: +42.29%
Ligand Pharmaceuticals
Jul 9, 2024
Maintains: Buy
Price Target: $135 → $140
Current: $114.64
Upside: +22.12%
Simulations Plus
Jul 3, 2024
Reiterates: Buy
Price Target: $56
Current: $28.58
Upside: +95.94%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $4.08
Upside: +145.10%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $19.44
Upside: +54.32%
Avid Bioservices
Dec 8, 2023
Maintains: Buy
Price Target: $22 → $16
Current: $12.30
Upside: +30.08%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $4.24
Upside: +65.09%
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $144.46
Upside: +38.45%
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $3.50
Upside: +185.71%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $9.44
Upside: +217.80%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $3.00
Upside: +13,233.33%